Showing results (211-220 of 285) with videos related to
Sort By:
Pageof 29
Plos One|December 11, 2012
Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db miceYoung-Eun Lee, Ji-Won Kim, Eun-Mi Lee, et al.International Journal of Stem Cells|December 4, 2013
A study on proliferation and behavior of retinal pigment epithelial cells on purified alginate filmsSu Mi Jeong, Eun Young Kim, Ji Hye Hwang, et al.Diabetes|June 11, 2016
Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in ObesityMira Ham, Sung Sik Choe, Kyung Cheul Shin, et al.Applied Clinical Informatics|September 29, 2016
Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in KoreaHun-Sung Kim, Yoo Jin Jeong, Sun Jung Baik, et al.Biomarkers in Medicine|November 23, 2011
Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetesJang-Won Son, Eun-Hee Jang, Mee-Kyoung Kim, et al.The Korean Journal of Internal Medicine|March 3, 2020
Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in KoreaJin-Hee Lee, Suk Chon, Seon-Ah Cha, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in ratsByung Ha Chung, Can Li, Bo Kyung Sun, et al.Journal of the American Heart Association|October 21, 2025
Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young AdultsJoonyub Lee, Minwoo Lee, Seung-Hwan Lee, et al.Diabetes, Obesity & Metabolism|November 6, 2020
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendationsChin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, et al.Cardiovascular Therapeutics|February 22, 2018
Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practiceHyunah Kim, Hyeseon Lee, Tong Min Kim, et al.Pageof 29